StockWatch
·

AIM ImmunoTech Inc. Q3 FY25 Results

AIMQ3 FY25 Results
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue0.030.0%25.0%
Total Income0.030.0%25.0%
Expenditure2.477.5%45.4%
PBT—
Net Profit-3.2817.6%11.3%
OPM—
NPM—
EPS1.57142.7%2716.7%
View full financials

Informational and educational content only. Not investment advice.